Correlation Between Axsome Therapeutics and OncoVista Innovative

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and OncoVista Innovative Therapies, you can compare the effects of market volatilities on Axsome Therapeutics and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and OncoVista Innovative.

Diversification Opportunities for Axsome Therapeutics and OncoVista Innovative

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Axsome and OncoVista is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and OncoVista Innovative go up and down completely randomly.

Pair Corralation between Axsome Therapeutics and OncoVista Innovative

Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 11.09 times less return on investment than OncoVista Innovative. But when comparing it to its historical volatility, Axsome Therapeutics is 7.92 times less risky than OncoVista Innovative. It trades about 0.15 of its potential returns per unit of risk. OncoVista Innovative Therapies is currently generating about 0.21 of returns per unit of risk over similar time horizon. If you would invest  0.01  in OncoVista Innovative Therapies on September 12, 2024 and sell it today you would earn a total of  0.01  from holding OncoVista Innovative Therapies or generate 100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Axsome Therapeutics  vs.  OncoVista Innovative Therapies

 Performance 
       Timeline  
Axsome Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axsome Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
OncoVista Innovative 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in OncoVista Innovative Therapies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak forward indicators, OncoVista Innovative unveiled solid returns over the last few months and may actually be approaching a breakup point.

Axsome Therapeutics and OncoVista Innovative Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Axsome Therapeutics and OncoVista Innovative

The main advantage of trading using opposite Axsome Therapeutics and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.
The idea behind Axsome Therapeutics and OncoVista Innovative Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years